Latest News

Pq Bypass News 2

PQ Bypass Announces Unconditional IDE Approval from U.S. FDA for Pivotal Study.

8th October 2019

MILPITAS, Calif. & Dublin, Ireland.  October 8, 2019. PQ Bypass Announces Unconditional IDE Approval from U.S. FDA to Start TORUS SFA Stent Graft Pivotal Study (TORUS-2) Seroba’s portfolio company, PQ Bypass, Inc., a clinical-stage medical device company, today announced it […]

Read More
Treating Heart Failure

Endotronix Closes Expanded Series D Round

1st October 2019

Lisle, IL & Dublin Ireland – Oct 1, 2019   Seroba’s investee company, Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure (HF), today announced the expansion of its Series D financing round, bringing the […]

Read More
Storm RNA Epigenetics Conference

STORM Therapeutics Presents Breakthrough Data at RNA Epigenetics Conference.

18th September 2019

STORM Therapeutics presents breakthrough data showing in vivo efficacy and therapeutic proof of concept for targeting RNA modifying enzymes. 18 September 2019, Cambridge, UK.  STORM Therapeutics, the biotechnology company focused on the discovery of small molecule therapies modulating RNA epigenetics, […]

Read More
Endotronix News

FDA Approval for Endotronix Pivotal Trial

1st August 2019

Dublin, Ireland and LISLE, IL, USA – AUGUST 1, 2019 – Seroba’s portfolio company, Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced it has received conditional Investigational Device […]

Read More
Quanta News

Quanta Raises $48 million in Series C Funding Round

29th July 2019

Alcester, Warwickshire, UK, 29 July 2019.  Seroba’s portfolio company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a British medical technology company developing a personal haemodialysis system (SC+) for patient use in the clinic and the home, today announced that […]

Read More
Endotronix News

Endotronix Enrolls 1st Patient in SIRONA II CE Mark Trial

16th July 2019

LISLE, IL – JULY 15, 2019 – Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure, today announced enrollment of the first patient in its prospective, multi-center, SIRONA II trial, in Europe.  […]

Read More
T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19
Ireland

Scroll to Top